Literature DB >> 9336401

Role of endogenous carbon monoxide in central regulation of arterial pressure.

R A Johnson1, E Colombari, D S Colombari, M Lavesa, W T Talman, A Nasjletti.   

Abstract

We investigated the contribution of neural mechanisms to the arterial pressure increase produced by zinc deuteroporphyrin 2,4-bis glycol (ZnDPBG), an inhibitor of endogenous carbon monoxide synthesis. The arterial baroreceptor reflex control of heart rate was examined in rats with and without ZnDPBG pretreatment (45 micromol/kg IP) by analysis of the arterial pressure-heart rate relationship during infusions of phenylephrine or sodium nitroprusside to vary arterial pressure. ZnDPBG increased arterial pressure from 110 +/- 3 to 126 +/- 2 mm Hg without eliciting bradycardia. The maximum gain of the heart rate response to changes in arterial pressure was attenuated by ZnDPBG treatment (-1.9 +/- 0.3 versus -4.8 +/- 1.0 bpm/mm Hg). The possibility that ZnDPBG elevates arterial pressure by attenuating baroreceptor reflex function was addressed by comparing the pressor response to ZnDPBG (45 micromol/kg IP) in rats with and without sinoaortic denervation. The pressor effect of ZnDPBG was similar in rats with and without arterial baroreceptor deafferentation, implying that the increase in pressure is not simply the consequence of attenuated baroreceptor reflex function per se. The possibility that ZnDPBG increases arterial pressure via an effect on the nucleus tractus solitarii (NTS) also was investigated. ZnDPBG (1 nmol in 100 nL) injected into the NTS of rats increased arterial pressure from 111 +/- 4 to 126 +/- 5 mm Hg, and this effect was reversed by an ipsilateral microinjection of carbon monoxide into the NTS. Accordingly, the pressor effect of ZnDPBG may rely on inhibition of carbon monoxide production in the NTS. This implies that carbon monoxide formed by brain heme oxygenase plays a role in the central regulation of arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9336401     DOI: 10.1161/01.hyp.30.4.962

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

Review 1.  Self-cytoprotection against stress: feedback regulation of heme-dependent metabolism.

Authors:  P M Schwartsburd
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

Review 2.  The role of heme oxygenase signaling in various disorders.

Authors:  Arpad Tosaki; Dipak K Das
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

Review 3.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

Review 4.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat.

Authors:  Noha N Nassar; Guichu Li; Aurel L Strat; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2011-07-18       Impact factor: 4.030

6.  Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.

Authors:  Robert T Kinobe; Jason Z Vlahakis; Hendrik J Vreman; David K Stevenson; James F Brien; Walter A Szarek; Kanji Nakatsu
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 7.  Targeting heme oxygenase-1 in vascular disease.

Authors:  William Durante
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

8.  Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors.

Authors:  J I Kaide; F Zhang; Y Wei; H Jiang; C Yu; W H Wang; M Balazy; N G Abraham; A Nasjletti
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

9.  Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension.

Authors:  Trinity Vera; Silvia Kelsen; David E Stec
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

Review 10.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.